1. Repurposing the FDA‐approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species. Issue 2 (6th May 2021) Authors: Liu, Lin; Jiang, Tong; Zhou, Jia; Mei, Yikun; Li, Jinyang; Tan, Jingcong; Wei, Luqi; Li, Jingquan; Peng, Yibing; Chen, Changbin; Liu, Ning‐Ning; Wang, Hui Other Names: Guo Jinshan guestEditor. Journal: Microbial biotechnology Issue: Volume 15:Issue 2(2022) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗